StockGlow

Psyence Biomedical Ltd. (PBM)

Develops psilocybin-based medicines to treat cancer patients' emotional distress

$3.16+0.04%Healthcare
Compare PBM with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-96.6%

The outlook

PBM is trading near its 52-week low with minimal analyst coverage. The stock sits below both its 50- and 200-day moving averages, reflecting a weak near-term trend. Market sentiment appears notably bearish based on available data.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
—
52-wk high
$371.09
52-wk low
$1.92
50-day avg
$3.39
200-day avg
$29.77
Trailing P/E
—

Similar stocks

RENXRenX Enterprises Corp.$1.78-9.64%GXAIGaxos.ai Inc.$0.84-22.94%MIRAMIRA Pharmaceuticals, Inc.$0.84-4.78%CMNDClearmind Medicine Inc.$1.46-8.92%CEROCERo Therapeutics Holdings, Inc.$0.01+27.84%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy